Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

INTRODUCTION: The incidence and prevalence of type 2 diabetes mellitus (T2D) are increasing in Japan, and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used to treat the disease. The objective of this study was to use a discrete choice experiment (DCE) to characterize patient pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Anne, Langer, Jakob, Tervonen, Tommi, Hemmingsen, Mads Peter, Eguchi, Kosei, Bacci, Elizabeth Dansie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437254/
https://www.ncbi.nlm.nih.gov/pubmed/30847838
http://dx.doi.org/10.1007/s13300-019-0591-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437254/
https://www.ncbi.nlm.nih.gov/pubmed/30847838
http://dx.doi.org/10.1007/s13300-019-0591-9

Ejemplares similares